奥雷辛A通过抑制NEK7/NLRP3通路来缓解慢性大脑低 perfusion诱导的神经炎症和认知功能障碍
Yong Chen1, Qianhui Zhou2, Lang Su2
1The Second affiliated Hospital of Nanchang University, Jiang Xi Medical College, Nanchang University, Nanchang 330003, Jiangxi, China; Jiangxi Province key of Laboratory of Anesthesiology, Nanchang 330006, China.
Experimental neurology
|July 22, 2025
概括
素A治疗通过减少神经炎症和神经元灭,改善了血管痴呆模型中的认知功能. 它通过NEK7/NLRP3途径恢复微质平衡,为认知障碍提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 神经炎症是一种神经炎症.
- 血管痴呆症研究研究
背景情况:
- 慢性大脑缺血 (CCH) 通过NLRP3炎症酶激活加剧了血管痴呆 (VaD) 中的神经炎症.
- 素A在缓解急性炎症反应方面表现有前途,但其在CCH诱导的认知衰退中的作用尚不清楚.
研究的目的:
- 在VaD的老鼠模型中研究Orexin A对认知功能的神经保护作用.
- 阐明涉及微质激活和NLRP3炎症酶通路的潜在机制.
主要方法:
- 通过永久的双边常见动脉阻塞建立了VaD鼠标模型.
- 进行了鼻腔内注射Orexin A治疗,并使用低氧BV2微质细胞与HT22神经元共同培养进行了体外实验.
主要成果:
- CCH大鼠表现出认知缺陷,降低了Orexin A/OXR1表达,激活了NLRP3炎症酶,M1微质,BBB干扰和神经退行.
- 素A治疗改善了这些CCH诱导的变化.
- 在体外,Orexin A抑制了微质中缺氧诱导的NLRP3激活,降低了热,并促进了M1到M2微质过渡,NEK7过度表达逆转了效应.
结论:
- 素A通过抑制NEK7/NLRP3通路恢复M1/M2微质平衡,从而减少神经炎症和神经元灭.
- 这种机制改善了CCH后的认知功能障碍,突出了Orexin A作为潜在的认知障碍治疗剂.
关键词:
慢性大脑低 perfusion 的时间.微质细胞中的微质细胞在NEK7中,NEK7是NEK7.在NLRP3炎症酶体中,NLRP3炎症神经再生是一种神经再生.素-A是一种素.血管痴呆症是一种精神疾病.更多相关视频
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
5.5K
03:26Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
Published on: December 8, 2023
1.3K
相关概念视频
01:24Sleep-Wake Cycles
1.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.6K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
209
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
209